FULCRUM THERAPEUTICS INC (FULC) Stock Income Statement
NASDAQ:FULC • US3596161097
Current stock price
7.84 USD
-0.24 (-2.97%)
At close:
7.65 USD
-0.19 (-2.42%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 80.00M | 2.81M | 6.34M | 19.16M | |||
| Operating Expenses | 84.77M | 99.83M | 113.47M | 118.47M | 100.22M | |||
| Research and Development | 56.10M | 63.39M | 71.80M | 76.78M | 69.70M | |||
| Selling, General, and Administrative Expenses | 28.67M | 36.45M | 41.67M | 41.69M | 30.52M | |||
| Operating Income | -84.77M | -19.83M | -110.66M | -112.13M | -81.05M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 9.89M | 12.17M | 13.33M | 2.69M | 210.00K | |||
| Non Recurring Items | 0.00 | -2.06M | 0.00 | -430.00K | N/A | |||
| Income Before Taxes | -74.88M | -9.72M | -97.33M | -109.87M | -80.85M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -74.88M | -9.72M | -97.33M | -109.87M | -80.85M | |||
| EBITDA | -83.38M | -18.24M | -108.49M | -109.72M | -78.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.18 | -0.16 | -1.59 | -2.44 | -2.29 | |||
| Non GAAP EPS | -1.18 | -0.22 | -1.58 | -2.48 | -2.29 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -12.16% | -3470.05% | -1732.97% | -421.97% | |||
| Operating Profit Margin | N/A | -24.79% | -3945.24% | -1768.61% | -423.02% | |||
All data in USD